Online Submissions

Already have a Username/Password for Kardiologia Polska (Polish Heart Journal)?

Go to Login

Need a Username/Password?

Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines


Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at

Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website:


1.Kardiologia Polska publishes original papers and review papers (review papers invited by the Editorial Board only) short forms of case reports (clinical vignettes) and letters to the Editor. Other papers are published in Kardiologia Polska only if directly agreed upon with the Editorial Board or at its own initiative.

2.All the papers published by the Kardiologia Polska become property of the Polish Cardiac Society and the Editorial Board. They may be reprinted in part or in whole, or translated only with written permission of the Editorial Board.

3.Kardiologia Polska assumes no responsibility for statements, opinions and data contained in the published papers, announcements, advertisements or promotional materials.

4.By submitting a paper describing an experiment conducted in humans the authors declare that the procedures they followed complied with the Declaration of Helsinki (with respect to the principles of medical ethics that forbid the disclosure of patient names, initials or hospital record numbers). The information about the study having been approved by the relevant ethics committee and about the patient having provided informed consent to participate in the study should be included in the material and methods section of each paper in which the diagnostic or therapeutic intervention is not part of the standard of care.

5.Authors submitting manuscripts that present the results of clinical studies of drugs or medical procedures are expected to provide an exhaustive description of the funding of the study, of the sponsor’s role in the planning and execution of the study and in the analysis of results, and of the impact of the funding institution on the content of the paper. All these details should be provided in the form of a conflict of interest statement published at the end of the paper. Whatever the topic of the paper, international non-proprietary names of drugs should be used throughout the text. The international non-proprietary names of drugs should be in line with the nomenclature adopted by the Polish Pharmacological Society Nomenclature Committee.

6.The Editorial Board reserves the right to correct stylistic and terminological errors without consulting the authors.

7.The manuscripts are peer-reviewed. The Editorial Board also ascertains whether the papers fall within the scope of the journal and reserves the right to reject papers which do not satisfy this condition.

8.The manuscripts are submitted electronically using the Electronic Manuscript Submission panel available on our website. Manuscripts sent by post or email will not be accepted. The panel accepts files in the following formats: .doc, .xls, .xlt, .pps, .ppt, .rtf, .odt, .sxw, .txt, .jpg, .png, .gif, .psd and .tif. The Electronic Manuscript Submission panel provides step-by-step instructions to enable the authors to supply appropriate details and upload appropriate files. Manuscripts that are incomplete or do not meet the above technical requirements will not be accepted. It is possible to supply additional data and replace incorrect files. The title of the paper, the authors’ details and their affiliations, the abstract, the key words and the type of the paper should be entered in the relevant fields of the panel both in Polish and in English. The text of the paper is uploaded as a separate file. Please do not provide the authors details (personal details and institutional affiliations) in the file containing the text of the paper, as the reviews are anonymous: neither the reviewer knows who has authored the paper nor the authors know who has reviewed their paper. Tables may be included in the file containing the text of the paper or submitted in a separate file. Figures should be submitted in separate graphic files. Each manuscript should be accompanied by a cover letter personally signed by all the authors and prepared in accordance with the template provided on the Electronic Manuscript Submission website. The cover letter should be posted to the address of the editorial office: Kardiologia Polska, ul. Stawki 3a lok. 3, 00-193 Warszawa.

9.Abbreviations should always be explained upon their first mention in the text (also applicable to abstracts). Save for exceptional situations, no abbreviations should be used in the title of the paper.

10.Laboratory test results and the relevant reference ranges and standard deviations should all be expressed according to the International System of Units (SI units) with the exception of certain parameters, such as lipid profile parameters and glucose, which are traditionally expressed in mg/dL.

11.The authors do not receive any remuneration for having their paper published in Kardiologia Polska. If the authors insist that some or all of the figures should be printed in colour but the Editorial Board does not consider it necessary, it is possible to print the figures in colour but the authors must first pay an additional fee determined by the Editorial Board.


1.Original papers

Original papers should be written in grammatical English. Manuscripts insuficient in proper English will not be consider for rewiev. Editorial Board as well as Publisher reserve the rights to put the mansuscript into acceptable form. The original paper should not exceed 15 pages (including the references) written in Times New Roman, 12 points, double-spaced with a 2.5-cm margin on each side.
The original paper should be structured as follows:
(1) The title should be concise and accurately reflect the topic of the paper. The first names, surnames and affiliations of all the authors and the address for correspondence should all be complete, correct and up-to-date. Those information should be submitted in the system, not put in the body of text. The author who uploads the paper in the system will be the corresponding author to whom all the correspondence related to the paper will be sent. He or she is also obliged to provide all the remaining authors with information on the status of the paper and on any changes.
(2) The abstract should consist of the following sections: Introduction, Aim, Methods, Results, and Conclusions. The abstract in Polish should contain between 500 and 800 words and the abstract in English between 250 and 400 words. For foregin authors, whose manuscript was accepted for publication, Editorial Board with the Publisher offer assistance with preparation of abstract in Polish language.
(3) Between 2 and 5 key words related to the paper’s topic should be provided in both languages. The text of the paper should be clearly divided into the following sections: Introduction, Methods, Results, Discussion, Conclusions, and References.
(4) The introduction should summarise the state of the art within the topic being studied and explain the aim of the study and the extent to which the study is original.
(5) The methods section provides a description of the study population, research methods and the statistical analysis.
(6) The results section should be written in a very clear manner. The authors should bear it in mind that curves and bar charts are more legible than tables and results merely mentioned in the text. Repetition of numerical data in the text should be avoided, if they are already presented in figures or tables.
(7) The discussion section should state to what degree the authors managed to achieve the study aims, which should be followed by a discussion to what extent the results are original (or whether they are merely consistent with findings presented in other Polish or foreign publications), what are the methodological limitations of the study, if any, what are the possible mechanisms of the phenomenon described in the paper, what might be the clinical relevance of the facts discovered in the study. The results should be discussed in the context of bibliographical data rather than providing a mere presentation of the current bibliographical data related to the topic addressed in the paper. The results presented in the results section should not be repeated in the discussion section.
(8) The conclusions should refer to the aims of the study and be presented using a particularly precise language.
(9) The references should list all the bibliographical sources cited in the text, in the order of their appearance. The following should be provided: (a) consecutive number; (b) surname(s) of the author(s) along with the first letter of the first name(s) (in the case of more than 3 authors the surnames of the first three authors should be provided and followed by ‘et al.’); (c) title of the paper, journal name using the applicable abbreviations (see Index Medicus), year, volume, issue number, first and last pages; for separate books: title and publisher, place and year of publication; (d) DOI numer of cited paper.

The reference list should be limited to the most relevant ones (up to 25). Citations in the text should be put in square brackets.

PLEASE NOTE: References should include DOI numbers of the cited papers (if applicable) – it will enable the references to be linked out directly to proper websites. (e.g. Redon J, Cifkova R, Laurent S, et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens. 2009; 27(3): 441–451, doi: 10.1097/HJH.0b013e32831e13e5.).

Tables should be numbered consecutively with the Arabic numerals. Each table should be titled and followed by appropriate clarifications. The position of tables should be indicated in the text. Tables should be submitted as .doc file.
Figures and photographs should be numbered consecutively with the Arabic numerals and submitted in separate files. Each figure and each photograph should be titled and its position in the text should be indicated. Figures and photographs should be submitted as .tif, .jpg or .gif files with a resolution of at least 300 dpi.
Titles of figures and photographs should be listed at the end of the main text after the reference list.

2.Clinical vignette

A clinical vignette is a brief description of an interesting, rare and clinically instructive case accompanied by 2 to 4 figures illustrating imaging study results or ECG tracings of good quality and resolution. A clinical vignette should not exceed 500 words (including title and titles of the figures), written in Times New Roman, 12 points, double-spaced with a 2.5-cm margin on each side. Clinical vignette should not be accompanied by a list of references, and is accepted for publication only in English. The number of authors of a clinical vignette cannot exceed five. Particularly interesting figures from the case description may be placed by the Editorial Board on the cover of the Journal, in the issue in which the given clinical vignette is printed. Figures and photographs should be numbered consecutively with the Arabic numerals and submitted in separate files. Each figure and each photograph should be titled and its position in the text should be indicated. Figures and photographs should be submitted as .tif, .jpg or .gif files with a resolution of at least 300 dpi. Titles of figures and photographs should be listed at the end of the main text.

3.Review papers

Kardiologia Polska do not accept review papers except STATE OF THE ART REVIEW which are published only upon Editorial Board initiative. They should not exceed 15 pages, including figures, tables and the reference list (up to 50 items), typed in Times New Roman 12 with double spacing and 2.5-cm margins on each side. Review papers are printed only in English.

4.Experts' opinions, consensus and positions papers are published only after agreement with Polish Cardiac Society. If you wish to publishes in this section please contact Editorial of kardiologia Polska


All collaborators who have made significant and substantial contributions to a study are considered coauthors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing of reagents or analytic tools, should be listed in the Acknowledgements. Ghostwriting and guest-authorship are forbidden. In case of detecting ghost written manuscripts, actions will be taken involving both the submitting authors and the participants involved.

Author statement

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).

  2. The submission file is in OpenOffice, Microsoft Word or RTF document file format.

  3. Where available, URLs for the references have been provided.

  4. The text is written using font size 12 and double-space between the lines; employs italics, rather than underlining (except with URL addresses); all illustrations, figures, and tables are  attached in separate file(s). Figures should be submitted in separate files.

  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.

  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

  7. The cover letter has been signed by all author(s) and is ready to be downlowaded.

Copyright Notice

All articles published by Kardiologia Polska become a property of the Polish Cardiac Society and the Editor. Reprints of both whole articles and extracts, as well as translations to other languages can be produced only after obtaining permission from the Editor.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: